glp-1 telehealth crackdown news today FEDS CRACK DOWN ON COMPANIES SELLING GLP-1s: The U.S. Food and Drug Administration is cracking down on telehealth companies for making “false and misleading” claims about compounded versions of popular weight New project announcement: HHS‑OIG is

Engage in Regular Physical Activity Even if youre not lifting weights, maintaining an active lifestyle through walking, yoga, or bodyweight exercises can help minimize muscle loss

We then performed two-sample MR and colocalization analyses to estimate the causal effect of GLP-1R-based agonists on MASLD, its metabolic risk factors, and multi-organ complications

Peptides for weight loss include GLP-1 receptor agonist medications such as Wegovy and Saxenda, as well as dual GIP/GLP-1 receptor agonists like Zepbound

Patients seeking GLP-1 therapy should rely on FDA-approved medications with established efficacy profiles, including landmark trials like STEP (semaglutide) demonstrating approximately 15% body weight reduction and SCALE (liraglutide) showing 5-8% weight reduction, along with improved glycemic control in patients with diabetes

But I was never able to lose weight, and that was really frustrating for me. Serena recalls a trip to Paris, in particular, during which she routinely walked 20,000 to 30,000 steps per daypartially because she loves strolling Paris (who doesnt!?) and partially because she was trying to get fit

All protocols, dosages, and treatment insights referenced herein are based on published literature